MoneyWorks4Me

Kilpest India informs about business updates

01 Dec 2020 Evaluate

Kilpest India has informed about the update for the month ending November, 2020. The company has sold 6,10,100 COVID-19 RT-PCR Tests in the month of November, 2020 with an average price of Rs 148 per test. The export license for RT-PCR specific orders was opened from 19-21 October 2020, the company applied & got license to export the long pending orders mainly for non-COVID kits, which the company has exported worth Rs 65,00,000. Thereafter the restrictions continue till further license window opens.

The above information is a part of company’s filings submitted to BSE.

3B Blackbio Dx Share Price

1445.00 -76.70 (-5.04%)
08-Sep-2026 13:19 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 693.55
Poly Medicure 1727.95
Molbio Diagnostics 1114.35
Laxmi Dental 197.00
Nureca 313.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: